64 related articles for article (PubMed ID: 38608077)
1. Deciphering age-specific molecular features in cervical cancer and constructing an angio-immune prognostic model.
Zhao X; Fan X; Lin X; Guo B; Yu Y
Medicine (Baltimore); 2024 Apr; 103(15):e37717. PubMed ID: 38608077
[TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
[TBL] [Abstract][Full Text] [Related]
3. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
[TBL] [Abstract][Full Text] [Related]
4. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
5. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
6. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
Song Z; Su M; Li X; Xie J; Han F; Yao J
BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
[TBL] [Abstract][Full Text] [Related]
7. Genetic insights into the age-specific biological mechanisms governing human ovarian aging.
Ojavee SE; Darrous L; Patxot M; Läll K; Fischer K; Mägi R; Kutalik Z; Robinson MR
Am J Hum Genet; 2023 Sep; 110(9):1549-1563. PubMed ID: 37543033
[TBL] [Abstract][Full Text] [Related]
8. TMEM33 as a Prognostic Biomarker of Cervical Cancer and Its Correlation with Immune Infiltration.
Zhang H; Wang J; Yang J; He Q; Guan S; Qiao M; Zhao J; Wang X
Mediators Inflamm; 2023; 2023():5542181. PubMed ID: 37273452
[TBL] [Abstract][Full Text] [Related]
9. Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy.
Subramanian M; Kabir AU; Barisas D; Krchma K; Choi K
Cell Rep Med; 2023 Jan; 4(1):100896. PubMed ID: 36630952
[TBL] [Abstract][Full Text] [Related]
10. Age-associated differences in the cancer molecular landscape.
Chatsirisupachai K; Lagger C; de Magalhães JP
Trends Cancer; 2022 Nov; 8(11):962-971. PubMed ID: 35811230
[TBL] [Abstract][Full Text] [Related]
11. Circular RNAs as emerging players in cervical cancer tumorigenesis; A review to roles and biomarker potentials.
Najafi S
Int J Biol Macromol; 2022 May; 206():939-953. PubMed ID: 35318084
[TBL] [Abstract][Full Text] [Related]
12. Age at Diagnosis Impacts Molecular and Clinical Properties of Tumors.
Cancer Discov; 2022 Mar; 12(3):596. PubMed ID: 35064031
[TBL] [Abstract][Full Text] [Related]
13. Cervical Carcinoma: Oncobiology and Biomarkers.
Volkova LV; Pashov AI; Omelchuk NN
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830452
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]